Warehouse Overstock Promotion |  Save 10%  on Premium Lab Supplies |  Shop Now

Menu

This product has been added to the cart.

Recombinant Mouse ALK-5/TGFBR1 (C-Fc)

SKU: PKSM041408-50

  • $ 74695
  • Save $ 9000


Request a Quote

Recombinant Mouse ALK-5/TGFBR1 (C-Fc)

 

SKU # PKSM041408
Expression Host HEK293 Cells

 

 

Description

Synonyms 53kD, AAT5, ACVRLK4, ALK-5, ALK-5ALK5, LDS1A, LDS2A, SKR4, TGF-bRI, TGF-beta receptor type I, TGFB1R1, TGFBR1, TGFR-1, TGFbetaRI, activin A receptor type II-like kinase, tbetaR-I
Species Mouse
Expression Host HEK293 Cells
Sequence Leu30-Glu125
Accession Q64729
Calculated Molecular Weight 37.6 kDa
Observed Molecular Weight 40-60 kDa
Tag C-Fc
Bio-activity Not validated for activity
  

 

Properties

Purity > 95 % as determined by reducing SDS-PAGE.
Endotoxin < 1.0 EU per μg of the protein as determined by the LAL method.
Storage Generally, lyophilized proteins are stable for up to 12 months when stored at -20 to -80℃. Reconstituted protein solution can be stored at 4-8℃ for 2-7 days. Aliquots of reconstituted samples are stable at < -20℃ for 3 months.
Shipping This product is provided as lyophilized powder which is shipped with ice packs.
Formulation Lyophilized from a 0.2 μm filtered solution of PBS, pH 7.4.
Normally 5% - 8% trehalose, mannitol and 0.01% Tween 80 are added as protectants before lyophilization.
Please refer to the specific buffer information in the printed manual.
Reconstitution Please refer to the printed manual for detailed information.



Background

TGF-beta RI, also called ALK-5, is an approximately 55 kDa type I transmembrane serine/threonine receptor kinase. In the presence of TGF-beta, TGF-beta RI forms a complex with, and is phosphorylated by, TGF-beta RII. Phosphorylated TGF-beta RI can then transiently bind and phosphorylate Smad2 and Smad3. TGF-beta functions as a tumor suppressor by inhibiting the cell cycle in the G1 phase. Administration of TGF-beta is able to protect against mammary tumor development in transgenic mouse models in vivo. Disruption of the TGF-beta/SMAD pathway has been implicated in a variety of human cancers, with the majority of colon and gastric cancers being caused by an inactivating mutation of TGF-beta RII. TGF-beta RI is likely important during development, since mice deficient for TGF-beta RI die at midgestation with severe defects in vascular development of the yolk sac and placenta, and an absence of circulating red blood cells. Furthermore, TGF-beta RI appears to be involved in proper lymphatic network development.